HI
BLFS

Harbour Investments’s BioLife Solutions BLFS Stock Holding History

Harbour Investments’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21.1K Sell
747
-34
-4% -$795 ﹤0.01% 2919
2026
Q1 		$14.9K Buy
+781
New +$17.3K ﹤0.01% 3053
2021
Q4 		– Sell
-10
Closed – – 2729
2021
Q3 		$0 Buy
10
+3
+43% +$144 ﹤0.01% 3741
2021
Q2 		$0 Buy
7
+1
+17% +$35 ﹤0.01% 3770
2021
Q1 		$0 Buy
+6
New +$237 ﹤0.01% 3599

Other funds holding BLFS

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Harbour Investments's BLFS Position: Q2 2026 in Review

Harbour Investments reduced its BioLife Solutions (BLFS) stake by 4.4% in Q2 2026, selling an estimated $795 and leaving 747 shares worth $21.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2919.

Harbour Investments first reported a position in BLFS in Q1 2021 and has held it in 5 quarters since. 216 funds tracked by Wall St. Rank hold BLFS as of Q2 2026.

  • Harbour Investments held 747 shares of BioLife Solutions worth $21.1K as of Q2 2026.
  • Harbour Investments sold 34 BioLife Solutions shares in Q2 2026, an estimated $795.
  • BioLife Solutions made up ﹤0.01% of Harbour Investments's portfolio in Q2 2026, its #2919 holding.
  • Harbour Investments first reported a position in BioLife Solutions in Q1 2021 and has held it in 5 quarters since.
  • 216 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2026.

Based on Harbour Investments's 13F filing for Q2 2026, filed 12 Aug 2026.